학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 65건 | 목록 1~20
Academic Journal
Vanhersecke L; Department of Biopathology, Institut Bergonié, Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: l.vanhersecke@bordeaux.unicancer.fr.; Bougouin A; Centre de Recherche des Cordeliers, Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne-Paris-Cité, Paris, France.; Crombé A; Department of Radiology, Centre Hospitalier Universitaire Bordeaux, Pessac, France.; Brunet M; University of Bordeaux, Bordeaux, France; Department of Oncology, Institut Bergonié, Bordeaux, France.; Sofeu C; Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Bordeaux, France.; Parrens M; University of Bordeaux, Bordeaux, France; Department of Pathology, Centre Hospitalier Universitaire Bordeaux, Pessac, France.; Pierron H; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Bonhomme B; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Lembege N; Department of Biopathology, Institut Bergonié, Bordeaux, France; University of Bordeaux, Bordeaux, France.; Rey C; Explicyte Immuno-Oncology, Bordeaux, France.; Velasco V; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Soubeyran I; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Begueret H; Department of Pathology, Centre Hospitalier Universitaire Bordeaux, Pessac, France.; Bessede A; Explicyte Immuno-Oncology, Bordeaux, France.; Bellera C; Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Bordeaux, France.; Scoazec JY; Department of Pathology, Gustave Roussy, Villejuif, France; Faculté de Médecine, Université Paris Saclay, Le Kremlin Bicêtre, France.; Italiano A; University of Bordeaux, Bordeaux, France; Department of Oncology, Institut Bergonié, Bordeaux, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1218, Institut Bergonié, Bordeaux, France.; Fridman CS; Centre de Recherche des Cordeliers, Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne-Paris-Cité, Paris, France.; Fridman WH; Centre de Recherche des Cordeliers, Institut national de la santé et de la recherche médicale (INSERM), Université Sorbonne-Paris-Cité, Paris, France.; Le Loarer F; Department of Biopathology, Institut Bergonié, Bordeaux, France; University of Bordeaux, Bordeaux, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1218, Institut Bergonié, Bordeaux, France.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE
Academic Journal
Vanhersecke L; Department of Pathology, Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Brunet M; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Department of Medicine, Institut Bergonié, Bordeaux, France.; Guégan JP; Explicyte Immuno-Oncology, Bordeaux, France.; Rey C; Explicyte Immuno-Oncology, Bordeaux, France.; Bougouin A; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université de Paris, Paris, 75006 France.; Cousin S; Department of Medicine, Institut Bergonié, Bordeaux, France.; Moulec SL; Clinique Marzet, Department of Oncology, Pau, France.; Besse B; Gustave Roussy, Department of Medicine, Villejuif, France.; Loriot Y; Gustave Roussy, Department of Medicine, Villejuif, France.; Larroquette M; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Department of Medicine, Institut Bergonié, Bordeaux, France.; Soubeyran I; Department of Pathology, Institut Bergonié, Bordeaux, France.; Toulmonde M; Department of Medicine, Institut Bergonié, Bordeaux, France.; Roubaud G; Department of Medicine, Institut Bergonié, Bordeaux, France.; Pernot S; Department of Medicine, Institut Bergonié, Bordeaux, France.; Cabart M; Department of Medicine, Institut Bergonié, Bordeaux, France.; Chomy F; Department of Medicine, Institut Bergonié, Bordeaux, France.; Lefevre C; Department of Medicine, Institut Bergonié, Bordeaux, France.; Bourcier K; Department of Medicine, Institut Bergonié, Bordeaux, France.; Kind M; Department of Radiology, Institut Bergonié, Bordeaux, France.; Giglioli I; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université de Paris, Paris, 75006 France.; Sautès-Fridman C; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université de Paris, Paris, 75006 France.; Velasco V; Department of Pathology, Institut Bergonié, Bordeaux, France.; Courgeon F; Explicyte Immuno-Oncology, Bordeaux, France.; Oflazoglu E; Astra Zeneca, Rahway, New Jersey, USA.; Savina A; Astra Zeneca, Rahway, New Jersey, USA.; Marabelle A; Gustave Roussy, Department of Medicine, Villejuif, France.; Soria JC; Gustave Roussy, Department of Medicine, Villejuif, France.; Bellera C; Clinical Research and Clinical Epidemiology Unit (ISO 9001 Certified), Institut Bergonié, Comprehensive Cancer Centre, 229 Cours de l'Argonne, 33076 Bordeaux, France.; Sofeu C; Clinical Research and Clinical Epidemiology Unit (ISO 9001 Certified), Institut Bergonié, Comprehensive Cancer Centre, 229 Cours de l'Argonne, 33076 Bordeaux, France.; Bessede A; Explicyte Immuno-Oncology, Bordeaux, France.; Fridman WH; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université de Paris, Paris, 75006 France.; Loarer FL; Department of Pathology, Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Italiano A; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Department of Medicine, Institut Bergonié, Bordeaux, France.; Gustave Roussy, Department of Medicine, Villejuif, France.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Moyeh MN; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon. marcel.moyeh@ubuea.cm.; Department of Biochemistry and Molecular Biology, University of Buea, Buea, South West Region, Cameroon. marcel.moyeh@ubuea.cm.; The Laboratory for Public Health Research Biotechnologies (LAPHER- Biotech), Yaoundé, Center Region, Cameroon. marcel.moyeh@ubuea.cm.; Shey RA; Department of Biochemistry and Molecular Biology, University of Buea, Buea, South West Region, Cameroon.; Mbulli AI; The Laboratory for Public Health Research Biotechnologies (LAPHER- Biotech), Yaoundé, Center Region, Cameroon.; Department of Biochemistry, University of Dschang, Dschang, West Region, Cameroon.; Dieudonne NL; Department of Biochemistry and Molecular Biology, University of Buea, Buea, South West Region, Cameroon.; Sofeu-Feugaing DD; Department of Biochemistry and Molecular Biology, University of Buea, Buea, South West Region, Cameroon.; Yega VA; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon.; Talla RN; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon.; Soh-Bang C; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon.; Sherinyuy BC; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon.; Ngengang AC; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon.; Chick JA; Department of Chemical and Biological Engineering, University of Bamenda, Bamenda, North West Region, Cameroon.; Mbacham WF; The Laboratory for Public Health Research Biotechnologies (LAPHER- Biotech), Yaoundé, Center Region, Cameroon. wfmbacham@yahoo.com.; Department of Biochemistry, University of Yaoundé 1, Yaoundé, Center Region, Cameroon. wfmbacham@yahoo.com.; Fobang Institutes for Innovations in Science & Technology (FINISTECH), Yaoundé, Centre Region, Cameroon. wfmbacham@yahoo.com.
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Sofeu, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어